SCHEMBL458491

SCHEMBL458491

Cc1ccc(S)c(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9194254 0.79
SCHEMBL29373274 0.75
SCHEMBL331198 0.75
SCHEMBL29441288 0.75
SCHEMBL130515 0.75
SCHEMBL234687 0.72
Hydrochloric Acid SCHEMBL31606798 0.72 CYP2A6 (0.43)
SCHEMBL29511362 0.72
SCHEMBL30929155 0.72 CYP2A6 (0.43)
SCHEMBL28693453 0.72 CYP2A6 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108640863-A Process for preparing bis (3-aminophenyl) disulfide and 3-aminothiol 拜尔农作物科学股份公司 2018-10-12 CN claimed
CN-104854085-A Process for preparing bis (3-aminophenyl) disulfide and 3-aminothiol BAYER CROPSCIENCE AG 2015-08-19 CN claimed
JP-61268690-A None JP disclosed
US-11945790-B2 Compounds and methods for treating autoimmune disorders by targeting HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. (US) 2024-04-02 US disclosed
WO-2023230543-A1 INDOLIZINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed
US-20220204471-A1 Compounds and Methods for Treating Autoimmune Disorders by Targeting HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. 2022-06-30 US disclosed
US-20220204471-A1 Compounds and Methods for Treating Autoimmune Disorders by Targeting HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. 2022-06-30 US disclosed
WO-2022140464-A1 COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS BY TARGETING HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed
WO-2021180107-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS FOCHON PHARMACEUTICALS, LTD. (CN) 2021-09-16 WO disclosed
US-10865208-B2 ATG7 inhibitors and the uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2020-12-15 US disclosed
US-10865208-B2 ATG7 inhibitors and the uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2020-12-15 US disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
US-20150368249-A1 FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) 2015-12-24 US disclosed
CN-104854085-A Process for preparing bis (3-aminophenyl) disulfide and 3-aminothiol BAYER CROPSCIENCE AG 2015-08-19 CN disclosed
US-20130338133-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-12-19 US disclosed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed
US-7169785-B2 Methods and compositions of novel triazine compounds REDDY US THERAPEUTICS, INC. (US) 2007-01-30 US disclosed
JP-S61268690-A ORGANIC PHOSPHORIC ACID ESTER DERIVATIVE AND INSECTICIDAL AND MITICIDAL COMPOSITION CONTAINING SAID DERIVATIVE AS ACTIVE COMPONENT NIPPON KAYAKU CO LTD 1986-11-28 JP disclosed